Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator: Results of the thrombolysis in myocardial infarction (TIMI) phase II-A trial

Circulation

Volumn 81, Issue 5, 1990, Pages 1457-1476

  Rogers, William J ^a,b   Baim, Donald S ^a   Gore, Joel M ^a   Greg Brown, B ^a   Roberts, Robert ^a   Williams, David O ^a   Chesebro, James H ^a   Babb, Joseph D ^a   Sheehan, Florence H ^a   Wackers, Frans J Th ^a   Zaret, Barry L ^a   Robertson, Thomas L ^a   Passamani, Eugene R ^a   Ross, Richard ^a   Knatterud, Genell L ^a   Braunwald, Eugene ^a  

^a Thrombolysis Myocardial I ^*  (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Clinical trials; Ejection fraction; Percutaneous transluminal coronary angioplasty; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; METHODOLOGY; MORTALITY; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; EXERCISE TEST; FEMALE; HUMAN; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; RADIONUCLIDE VENTRICULOGRAPHY; RANDOMIZED CONTROLLED TRIALS; STROKE VOLUME; SUPPORT, U.S. GOV'T, P.H.S.; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0025237750     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.81.5.1457     Document Type: Article

References (9)

1. Harrison DG, Ferguson DW, Collins SM, Skorton DJ, Ericksen EE, Kioschos JM, Marcus ML, White CW: Rethrombosis after reperfusion with streptokinase: Importance of geometry of residual lesions. Circulation 1984;69:991-999
2. Meyer J, Merx W, Schmilz H, Erbel R, Kiesslich T, Dorr R, Lambertz H, Bethge C, Krebs W, Bardos P, Minale C, Messmer J, Effert S: Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation 1982;66:905-913
3. Papapietro SE, MacLean WA, Stanley AW Jr, Hess RG, Corley N, Arciniegas JG, Cooper TB: Percutaneous transluminal coronary angioplasty after intracoronary streptokinase in evolving acute myocardial infarction. Am J Cardiol 1985;55:48-53
4. Topol EJ, Weiss JL, Brinker JA, Brin KP, Gottlieb SO, Becker LC, Bulkley BH, Chandra N, Flaherty JT, Gerstenblith G, Gottlieb SH, Guerci AD, Ouyang P, Llewellyn MP, Weisfeldt ML, Shapiro EP: Regional wall motion improvement after coronary thrombolysis with recombinant tissue plasminogen activator: Importance of coronary angioplasty. J Am Coll Cardiol 1985;6:426-433
5. Erbel R, Pop T, Henrichs KJ, von Olshausen K, Schuster CJ, Rupprecht HJ, Steuernagel C, Meyer J: Percutaneous transluminal coronary angioplasty after thrombolytic therapy: A prospective controlled randomized trial. J Am Coll Cardiol 1986;8:485-495
6. Sandler H, Dodge HT: The use of single plane angiocardiograms for the calculation of left ventricular volume in man. Am Heart J 1968;75:325-334
7. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J, Woo HW: Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 1986;74:293-305
8. Brown BG, Gallery CA, Badger RS, Kennedy JW, Mathey D, Bolson EL, Dodge HT: Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: Quantitative angiographic observations. Circulation 1986;73:653-661
9. Bruce RA, Hornsten TR: Exercise stress testing in evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis 1979;11:371-390